Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute
  • National Institutes of Health (P30 CA008748)

This publication has 17 references indexed in Scilit: